52 Result(s)

Article

Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas

Trichoblastic carcinoma is a rare malignant cutaneous adnexal tumor with a risk of local invasion and distant metastasis. As of today, there is no consensus for the treatment of locally advanced or metastatic ...

E. Toulemonde, S. Chevret, M. Battistella… in Cancer Immunology, Immunotherapy (2023)

Article

Intensive care medicine in 2050: clinical trials designs

M. Gasparini, S. Chevret in Intensive Care Medicine (2019)

Article

Lenalidomide-mediated erythroid improvement in non-del(5q) myelodysplastic syndromes is associated with bone marrow immuno-remodeling

G Kerdivel, V Chesnais, E Becht, A Toma, N Cagnard, F Dumont, A Rousseau… in Leukemia (2018)

Article

Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Greffe de Moelle Osseuse et Thérapie Cellulaire and Eurocord

Unrelated cord blood transplantation (UCBT) after a reduced intensity conditioning regimen (RIC) has extended the use of UCB in elderly patients and those with co-morbidities without an HLA-identical donor, al...

S Nguyen, A Achour, L Souchet, S Vigouroux, P Chevallier… in Bone Marrow Transplantation (2017)

Article

Monitoring antimicrobial resistance (AMR) using CUSUM control charts

We evaluated the use of the Cumulative Summation (CUSUM) control chart methodology for detection of an excessive increase in antimicrobial-resistant (AMR) bacteria acquisition. We used administrative, clinical...

L. Righi, R. Amarsy, M.-Q. Picat… in European Journal of Clinical Microbiology … (2017)

Article

Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion

After failure of erythropoiesis-stimulating agents (ESAs), lenalidomide (LEN) yields red blood cell (RBC) transfusion independence (TI) in 20–30% of lower-risk non-del5q myelodysplastic syndrome (MDS). Several...

A Toma, O Kosmider, S Chevret, J Delaunay, A Stamatoullas, C Rose… in Leukemia (2016)

Article

Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients

Intensive care unit (ICU) admission is associated with high mortality in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Whether mortality has decreased recently is unknown. The 497 adult allo...

E Lengliné, S Chevret, A-S Moreau, F Pène, F Blot… in Bone Marrow Transplantation (2015)

Article

Multiple imputation: a mature approach to dealing with missing data

S. Chevret, S. Seaman, M. Resche-Rigon in Intensive Care Medicine (2015)

Article

Prognosis of neutropenic patients admitted to the intensive care unit

The prognosis of critically ill cancer patients has improved recently. Controversies remain as regard to the specific prognosis impact of neutropenia in critically ill cancer patients. The primary objective of...

D. Mokart, M. Darmon, M. Resche-Rigon, V. Lemiale, F. Pène… in Intensive Care Medicine (2015)

Article

Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis

Bronchiolitis obliterans syndrome (BOS) after allogeneic hematopoietic SCT (HSCT) is recognized as a new-onset obstructive lung defect (OLD) in pulmonary function testing and is related to pulmonary chronic GV...

A Bergeron, C Godet, S Chevret, G Lorillon… in Bone Marrow Transplantation (2013)

Chapter

Time course of organ failure in patients with septic shock treated with hydrocortisone: results of the Corticus study

Introduction: Corticosteroids have been proposed to decrease morbidity and mortality in patients with septic shock. An impact on morbidity should be anticipated to be earlier and more easily detect...

R. Moreno, C. L. Sprung, D. Annane… in Applied Physiology in Intensive Care Medic… (2012)

Article

Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy

We retrospectively studied a series of 23 patients (median age 50 years, range 29–59 years) with multiple myeloma (MM), treated in first relapse by a sequential autologous–allogeneic tandem approach. Tandem tr...

L Karlin, B Arnulf, S Chevret, L Ades, M Robin… in Bone Marrow Transplantation (2011)

Article

Hematopoietic progenitor cell mobilization and harvesting in children with malignancies: do the advantages of pegfilgrastim really translate into clinical benefit?

Our purpose was to assess success rates in children of achieving optimal hematopoietic progenitor cells (HPCs) harvest after mobilization with 300 μg/kg pegfilgrastim. Between January 2005 and January 2007, 26...

E Merlin, S Zohar, C Jérôme, R Veyrat-Masson, G Marceau… in Bone Marrow Transplantation (2009)

Article

Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation

Bronchiolitis obliterans (BO) is a potentially life-threatening complication following allogeneic stem cell transplantation (SCT) and usually carries a poor prognosis. Immunosuppressive medications are the mai...

A Bergeron, A Belle, S Chevret, P Ribaud, A Devergie… in Bone Marrow Transplantation (2007)